Home > Boards > US Listed > Medical - Equipment > Edwards Life Sciences LLC (EW)

Edwards Lifesciences (NYSE:EW) reported EPS of $0.58 in

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
THESTCOKHUNTER Member Profile
 
Followed By 2
Posts 482
Boards Moderated 0
Alias Born 12/17/11
160x600 placeholder
Health-Care Stocks Get a Welcome Respite -- Update Dow Jones News - 10/15/2019 7:58:00 PM
Health-Care Stocks Get a Welcome Respite Dow Jones News - 10/15/2019 12:56:00 PM
Elizabeth Warren's Rise Is Battering Health-Care Stocks Dow Jones News - 10/15/2019 10:22:00 AM
Elizabeth Warren's Rise Is Battering Health-Care Stocks Dow Jones News - 10/15/2019 8:29:00 AM
Edwards Lifesciences To Host Earnings Conference Call On October 23, 2019 PR Newswire (US) - 10/9/2019 10:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/4/2019 7:12:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/4/2019 7:08:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 7:19:27 PM
Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients PR Newswire (US) - 9/29/2019 12:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2019 2:59:59 PM
Koa Accel Launches as New Type of Medical Device Accelerator, Embedding Expert, Invested Teams to Drive Innovations Forward, ... GlobeNewswire Inc. - 9/12/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 2:05:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2019 5:35:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/5/2019 7:17:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/3/2019 7:15:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2019 5:03:36 PM
Edwards Lifesciences To Present At The 2019 Wells Fargo Healthcare Conference PR Newswire (US) - 8/28/2019 11:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/21/2019 6:00:25 PM
Edwards SAPIEN 3 TAVR Receives FDA Approval For Low-Risk Patients PR Newswire (US) - 8/16/2019 11:55:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/16/2019 11:12:39 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/9/2019 2:46:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2019 11:33:39 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/1/2019 6:57:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/1/2019 6:56:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2019 2:54:34 PM
THESTCOKHUNTER   Sunday, 11/04/12 08:56:16 AM
Re: dfeickeesq post# 237
Post # of 276 
Edwards Lifesciences (NYSE:EW) reported EPS of $0.58 in the third quarter of 2012, surpassing the Zacks Consensus Estimate by $0.02. Sales increased 8.5% to $447.9 million, in line with the preliminary result but lagged the original guidance of $465-$485 million. This was primarily due to lower-than-expected THV sales due to economic uncertainties in Europe, coverage issues for certain inoperable patients in US and later-than expected approval of Sapien in high-risk patients.

Given these headwinds, the company lowered its outlook for 2012. We prefer to avoid the stock and accordingly downgrade it to Underperform.

Edwards current trailing 12-month earnings multiple is 36.3. The stock is currently trading at 27.1x the 2013 EPS estimate of $3.21. Our target price is based on 24.6x our 2013 EPS estimate.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist